Company Filing History:
1 out of 15 
1 out of 932 
1 out of 1 Years Active: 2000
Title: Claude A. Hariton: Innovator in Photodynamic Therapy
Introduction
Claude A. Hariton is a notable inventor based in Brinckhein, France. He has made significant contributions to the field of photodynamic therapy, particularly in the prevention of secondary cataracts. His innovative approach utilizes photosensitizers, such as green porphyrins, as photoactive agents to effectively destroy remnant lens epithelial cells.
Latest Patents
Hariton holds a patent for the "Use of photodynamic therapy for prevention of secondary cataracts." This patent highlights his pioneering work in employing photodynamic therapy to address a common complication in cataract surgery.
Career Highlights
Throughout his career, Hariton has worked with prominent organizations, including QLT Phototherapeutics, Inc. and the University of British Columbia. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic techniques.
Collaborations
Some of his notable coworkers include Howard E. Meadows and Danielle Wenkstern. Their collaborative efforts have further enriched the research landscape in photodynamic therapy.
Conclusion
Claude A. Hariton's work in photodynamic therapy represents a significant advancement in the prevention of secondary cataracts. His innovative approach and collaborations have made a lasting impact in the field of ophthalmology.